16:02 Dec 20
Marksans Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Marksans Pharma Ltd.
55/100 High Financial Strength
Quality28/100 Expensive Valuation
Valuation67/100 Technically Moderately Bullish
TechnicalSWOT
Strength
8
Weakness
3
Opportunity
1
Threat
0
13.82K
Market Cap (Cr)
39.82
PE Ratio
6.06
Price to Book Ratio
42.62
RSI
14.40 %
Net Profit Margin
Rating Based on 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 301 with a high estimate of 301 and low estimate of 301
Current 304.90
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
